^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AVENIO ctDNA Expanded Kit

Company:
Roche
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
The AVENIO ctDNA Expanded Kit is a next-generation sequencing (NGS) liquid biopsy assay with a 77 gene panel and emerging cancer biomarkers. The Expanded Kit is a pan-cancer assay that’s specially optimized for lung cancer and colorectal cancer (CRC). Accurate detection of all four classes of mutations with high sensitivity and specificity: >99% sensitivity for all four classes of mutations; >99% positive predictive value (PPV) for indels, fusions and CNVs, and >98% PPV for SNVs.
Cancer:
Colorectal Cancer, Lung Cancer
Gene:
ABL1 (ABL proto-oncogene 1), AKT1 (V-akt murine thymoma viral oncogene homolog 1), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), DPYD (Dihydropyrimidine Dehydrogenase)
See More ...
Method:
Next-Generation Sequencing (NGS)